IL1B and breast carcinoma: A similar elevation in GZMB levels was demonstrated in a breast cancer transplant model in Il1b-deficient mice, where a combination of anti–IL-1β synergized with anti–PD-1 antibodies to restore the function of anergized antitumor T cells and resulted in complete inhibition of tumor growth (43).